Authors : Callistus Obinna Elegbua; Surajdeen Tunde Afolayan; Harold Yiralee Doneh; Angela Adaku Elegbua; Wofai Ubi; Oiseremen Samuel Ovbiagele; Kester Obiora Ezewuzie; Jerome Tunde Herbert

Volume/Issue : Volume 9 - 2024, Issue 6 - June

Google Scholar : https://tinyurl.com/ecksm6m6

Scribd : https://tinyurl.com/yc5etawj

DOI : https://doi.org/10.38124/ijisrt/IJISRT24JUN378

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : This case report examines a poignant instance of severe preeclampsia in a 26 year old with a history of recurrent pregnancy loss and however, a prior vaginal delivery. The patient presented at 29 weeks gestation with acute lower abdominal pain with associated abruptio placentae, resulting in a stillbirth and disseminated intravascular coagulopathy (DIC). The intricate interplay of obstetric history and clinical management reveals the challenges in navigating such complex scenarios. The patient's obstetric history of recurrent miscarriages and a vaginal delivery with perineal tear signals a predisposition to adverse outcomes. The acute presentation of abruptio placentae underscores the imperative for heightened vigilance in pregnant women even in the absence of antenatal complaints. Successful resuscitation involved correcting shock, transfusing three units of blood and addressing hemorrhagic DIC. Tranexamic acid, pentazocine, normal saline, misoprostol and oxytocin were employed to stabilize the patient, highlighting the necessity of a comprehensive and multidisciplinary approach. This case serves as a stark reminder of the unpredictable nature of severe preeclampsia and emphasizes on the critical importance of early detection and intervention. Future research endeavors should focus on refining risk stratification models and exploring innovative interventions to enhance maternal and fetal outcomes in high-risk pregnancies.

References :

1. Phipps, Elizabeth, et al. "Preeclampsia: updates in pathogenesis, definitions, and guidelines." Clinical journal of the American Society of Nephrology: CJASN 11.6 (2016): 1102.
2. Gando, S., Levi, M., & Toh, C. H. (2016). Disseminated intravascular coagulation. Nature reviews Disease primers, 2(1), 1-16.
3. Friedman, S. A., Taylor, R. N., & Roberts, J. M. (1991). Pathophysiology of preeclampsia. Clinics in perinatology, 18(4), 661-682.
4. Ten Cate, H., Timmerman, J. J., & Levi, M. (1999). The pathophysiology of disseminated intravascular coagulation. Thrombosis and haemostasis, 82(08), 713-717.
5. Oyelese, Yinka, and Cande V. Ananth. "Placental abruption." Obstetrics & Gynecology 108.4 (2006): 1005-1016.
6. Tikkanen, M., Nuutila, M., Hiilesmaa, V., Paavonen, J., & Ylikorkala, O. (2006). Clinical presentation and risk factors of placental abruption. Acta obstetricia et gynecologica Scandinavica, 85(6), 700-705.
7. Ananth, Cande V., Gertrud S. Berkowitz, David A. Savitz, and Robert H. Lapinski. "Placental abruption and adverse perinatal outcomes." Jama 282, no. 17 (1999): 1646-1651.
8. Beune, Irene Maria, et al. "Consensus definition of fetal growth restriction in intrauterine fetal death: a Delphi procedure." Archives of pathology & laboratory medicine 145.4 (2021): 428-436.